Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
International journal of antimicrobial agents, 2020-05, Vol.55 (5), p.105954 [Peer Reviewed Journal]Copyright © 2020. Published by Elsevier B.V. ;EISSN: 1872-7913 ;DOI: 10.1016/j.ijantimicag.2020.105954 ;PMID: 32234467
Digital Resources/Online E-Resources
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||